Cambridge Investment Research Advisors’s Ardelyx ARDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$62K Buy
12,146
+1,000
+9% +$6.1K ﹤0.01% 3967
2026
Q1
$67K Buy
11,146
+216
+2% +$1.43K ﹤0.01% 3828
2025
Q4
$64K Buy
+10,930
New +$60.9K ﹤0.01% 3736
2025
Q1
– Sell
-11,475
Closed -$58K – 3505
2024
Q4
$58K Buy
11,475
+1,180
+11% +$6.52K ﹤0.01% 3367
2024
Q3
$71K Sell
10,295
-45
-0.4% -$266 ﹤0.01% 3304
2024
Q2
$77K Buy
+10,340
New +$72.7K ﹤0.01% 3184
2021
Q2
– Sell
-14,400
Closed -$95K – 3088
2021
Q1
$95K Hold
14,400
– – ﹤0.01% 2763
2020
Q4
$93K Buy
+14,400
New +$85.5K ﹤0.01% 2613

Other funds holding ARDX

Cambridge Investment Research Advisors's ARDX Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its Ardelyx (ARDX) stake by 9% in Q2 2026, buying an estimated $6.1K and bringing the position to 12,146 shares worth $62K. The position accounts for ﹤0.01% of the portfolio, ranked #3967.

Cambridge Investment Research Advisors first reported a position in ARDX in Q4 2020 and has held it in 8 quarters since. The position peaked at $95K in Q1 2021. 250 funds tracked by Wall St. Rank hold ARDX as of Q2 2026.

  • Cambridge Investment Research Advisors held 12,146 shares of Ardelyx worth $62K as of Q2 2026.
  • Cambridge Investment Research Advisors bought 1,000 Ardelyx shares in Q2 2026, an estimated $6.1K.
  • Ardelyx made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #3967 holding.
  • Cambridge Investment Research Advisors first reported a position in Ardelyx in Q4 2020 and has held it in 8 quarters since.
  • Cambridge Investment Research Advisors's Ardelyx position peaked at $95K in Q1 2021.
  • 250 funds tracked by Wall St. Rank held Ardelyx as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.